BTG plc: Directorate Change
London, UK, 1 November 2011: BTG plc (LSE: BGC), the specialist healthcare company, announces that Rolf Soderstrom, Chief Financial Officer, is leaving the Company in order to take up the role of Chief Financial Officer with a private multinational manufacturing organisation which is a global leader in its field. It is anticipated Mr Soderstrom will remain as Chief Financial Officer of BTG until the end of March 2012 to ensure a smooth handover to his successor, who is expected to be appointed in the next few months.
Louise Makin, BTG’s CEO, commented: “On behalf of the Board, I would like to thank Rolf for his significant contributions to BTG’s performance since joining as CFO following our acquisition of Protherics PLC in December 2008. Thanks to his strong financial management and leadership, we are in an excellent position to continue to deliver on our growth strategy.”
BTG is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The company is seeking to acquire new products to develop and market to specialist physicians, and is building a sustainable business financed by revenues from sales of its own marketed products and from royalties and milestone payments on partnered products.
For further information contact:
Andy Burrows, Director of Investor Relations
+44 (0)20 7575 1741; Mobile: +44 (0)7990 530605
Rolf Soderstrom, Chief Financial Officer
+44 (0)20 7575 0000
+44 (0)20 7831 3113